Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
EPB41L3
REST API REST API
Homo sapiens
EPB41L3 is differentially expressed in 296 experiments: 158 organism parts: liver, bone marrow, ... (156 more);, 214 disease states: normal, prostate carcinoma, ... (212 more);, 100 cell types 475 cell lines 26 compound treatments and 70 other conditions.
Synonyms 4.1B, KIAA0987, DAL1
Orthologs EPB41L3 (Gallus gallus)   Epb41l3 (Rattus norvegicus)   Epb4.1l3 (Mus musculus)   EPB41L3 (2 of 2) (Danio rerio)   ENSCING00000001753 (Ciona intestinalis)   epb41l3b (Danio rerio)   EPB41L3 (Bos taurus)   cora (Drosophila melanogaster)   epb41l3 (Xenopus laevis)   EPB41L3 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term extrinsic to membrane, plasma membrane, protein binding, cytoskeleton, cytoplasm, cell-cell junction, cortical actin cytoskeleton organization, structural molecule activity, biological_process, binding, cytoskeletal protein binding, actin binding, juxtaparanode region of axon, paranode region of axon
InterPro Term Ez/rad/moesin, FERM-adjacent, Band_4.1_C, FERM_central, Band_41_domain, FERM_domain, SAB, Band_41_fam, FERM_N, FERM_PH-like_C, Band_41_protein
UniProt Accession Q9Y2J2, B2RB02, A8K968, F5H7W5, F5GX05, E7EUF8
Search EB-eye ENSG00000082397
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-803, E-GEOD-15765, E-GEOD-1577, E-GEOD-3526, E-MTAB-62, ... (30 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-3860, E-GEOD-5258, E-GEOD-19639, E-GEOD-19397, ... (39 experiments)

Factor Value U/D Experiments
MCF-7
4
E-GEOD-19639, E-GEOD-3529, E-GEOD-20081, E-GEOD-5823
HL-60
3
E-GEOD-5258, E-MTAB-37, E-GEOD-24147
MOLT4
2
E-MTAB-62, E-MTAB-37
SW480
2
E-MEXP-1014, E-MTAB-37
T84
2
E-MTAB-37, E-GEOD-1474
BT474
1
2
E-MEXP-440, E-MTAB-37, E-MTAB-62
469 more value(s).


Cell type

studied in E-GEOD-20193, E-MEXP-1121, E-GEOD-21668, E-GEOD-3920, E-GEOD-20677, ... (52 experiments)

Factor Value U/D Experiments
endothelial cell
4
E-GEOD-96, E-GEOD-3920, E-GEOD-19240, E-GEOD-3998
mononuclear cell
3
E-GEOD-6053, E-MEXP-66, E-GEOD-7307
macrophage
1
3
E-GEOD-3982, E-GEOD-22373, E-GEOD-360, E-GEOD-8286
plasma cell
2
E-MEXP-2360, E-GEOD-6691
dendritic cell
2
E-GEOD-360, E-GEOD-3982
bronchial epithelial
2
E-AFMX-5, E-MTAB-25
94 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-GEOD-2466, E-MEXP-1121, E-GEOD-1577, ... (79 experiments)

Factor Value U/D Experiments
myeloma
3
E-MTAB-37, E-MTAB-62, E-MTAB-372
colon carcinoma
1
3
E-MTAB-62, E-MTAB-37, E-MTAB-57, E-GEOD-3726
Huntington's disease
2
E-AFMX-6, E-GEOD-3790
dermatomyositis
2
E-GEOD-1551, E-GEOD-5370
lymphoma
2
E-MTAB-62, E-MTAB-37
Duchenne muscular dystrophy
2
E-GEOD-1004, E-GEOD-3307
208 more value(s).


Compound treatment

studied in E-GEOD-7400, E-GEOD-15205, E-GEOD-5824, E-GEOD-5099, E-MEXP-941, ... (17 experiments)

Factor Value U/D Experiments
none
2
6
E-MEXP-1389, E-GEOD-5824, E-GEOD-412, E-GEOD-995, E-GEOD-20719, ... (8 experiments)
control - untreated
1
E-GEOD-7216
control - keratinocyte growth factor
1
E-GEOD-7216
glutamine
1
E-MEXP-941
vitamin E
1
E-MEXP-1327
TGF
1
1
E-GEOD-15205
20 more value(s).


A rna yield

studied in E-TABM-325

Factor Value U/D Experiments
113.9
1
1
E-TABM-325
112.03
1
1
E-TABM-325


Age at diagnosis
studied in E-GEOD-3494

Age at onset
studied in E-GEOD-21521

Agent
studied in E-GEOD-19519

Biosource provider
studied in E-MTAB-37

BioSourceProvider
studied in E-GEOD-19466, E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Cancer site
studied in E-GEOD-4271

cd38
studied in E-GEOD-22601

Cell treatment
studied in E-MEXP-1192

Clinical history
studied in E-TABM-234, E-GEOD-19743, E-GEOD-7967, E-GEOD-21589, E-GEOD-16363 ... (5 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-1140, E-GEOD-994, E-MEXP-1251, ... (11 experiments)

Clinical treatment
studied in E-GEOD-1743, E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

development stage
studied in E-GEOD-22601

Developmental stage
studied in E-GEOD-5999, E-GEOD-1638, E-GEOD-20033, E-MEXP-2359, E-MEXP-958, ... (6 experiments)

Disease staging
studied in E-GEOD-19743, E-GEOD-22544, E-GEOD-7788, E-MTAB-69, E-MEXP-2280, ... (8 experiments)

Environmental stress
studied in E-GEOD-1643, E-GEOD-1518

Estrogen receptor status
studied in E-GEOD-6532

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

Ethnicity
studied in E-GEOD-21589, E-GEOD-16363

family id
studied in E-GEOD-19519

Family relationship
studied in E-MEXP-1425

Genetic modification
studied in E-GEOD-8023, E-GEOD-7011, E-MEXP-1482, E-GEOD-7578, E-GEOD-20847, ... (8 experiments)

Genotype
studied in E-MEXP-149, E-GEOD-2466, E-GEOD-17476, E-GEOD-2292, E-TABM-868, ... (7 experiments)

Gestation age
studied in E-GEOD-14334

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-GEOD-20540, E-GEOD-20504, E-GEOD-19018, E-MEXP-1103, E-MEXP-1741, ... (7 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-TABM-276

Individual
studied in E-TABM-325, E-MTAB-197, E-TABM-740, E-GEOD-1926, E-MEXP-2069, ... (32 experiments)

Infection
studied in E-GEOD-12108, E-MEXP-561

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-22056

Material type
studied in E-MEXP-455, E-GEOD-9171

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-1801, E-GEOD-426, E-TABM-84

Organism status
studied in E-GEOD-19188

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-1309, E-GEOD-21750, E-GEOD-17636, E-GEOD-2487, E-MEXP-1403 ... (5 experiments)

Population
studied in E-GEOD-4922

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-3254, E-GEOD-21837, E-GEOD-19445, E-GEOD-19246, E-GEOD-1343 ... (5 experiments)

pt
studied in E-GEOD-21653

Replicate
studied in E-GEOD-10797, E-GEOD-18791

Rna integrity
studied in E-TABM-325

RNAi
studied in E-MEXP-2115, E-GEOD-12438, E-MEXP-101, E-GEOD-3697, E-MEXP-2759 ... (5 experiments)

Sample preparation
studied in E-GEOD-16728, E-GEOD-12710

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-21374, E-GEOD-17400

Sex
studied in E-GEOD-19069, E-GEOD-7307

Sirna
studied in E-GEOD-21575

Stimulation
studied in E-GEOD-4883

stimulus
studied in E-GEOD-22103

Strain or line
studied in E-TABM-125

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-3494, E-GEOD-4922, E-GEOD-19188

Test result
studied in E-GEOD-1926, E-TABM-276

tissue (organ)
studied in E-GEOD-22601

Treatment
studied in E-GEOD-16837, E-MEXP-973, E-GEOD-19246, E-GEOD-13818, E-GEOD-19815, ... (6 experiments)

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4290, E-GEOD-4922

Vehicle
studied in E-GEOD-5258

Processing time: 0.382 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM